MRC News

The Director-General of the World Health Organization, Dr Tedros Adhanom Ghebreyesus, on Sunday 24 October 2018 had visited the Mycetoma Research Centre in Khartoum (Sudan), WHO Collaborating Centre on Mycetoma where he pledged to support initiatives that

Read more...

The Mycetoma Research Centre which is a major hub of mycetoma research and training and will be hosting The Sixth International Conference on Mycetoma in the period 15-17 February 2019. It will be preceded by a training workshop on mycetoma.

The conference aims at providing an excellent forum for clinicians, scientists, social scientists, researchers, medical and health providers and students to deliberate critical issues in mycetoma, the challenges, opportunities, threats, budding problems in mycetoma, and to explore

Read more...

 

AmyMaxmen HeadShotFeb2013

Amy Maxmen
Amy Maxmen [www.amymaxmen.com] is an award-winning science writer who covers the entanglements of medicine, policy, nature and of people behind research. Her stories appear in a variety of outlets, including Wired, National Geographic, Nature, and the New York Times. From Sudan and the Democratic Republic of Congo, she's reported two series for Global Health NOW on the most neglected diseases. Her feature in Nautilus magazine on the origin of humanity is anthologized in The Best American Science and Nature Writing 2015. Prior to writing, she earned a PhD from Harvard University in evolutionary biology. Twitter: @amymaxmen Instagram: @amaxmen

 

 

Read more...

 

The Drugs for Neglected Diseases Initiative Is the Anti Martin Shkreli:

For the Global Health Untold Stories Contest of 2015, we and colleagues at the Consortium of Universities for Global Health received 170 nominations of diseases and issues that impact global health but receive little or no attention from the mainstream media.

After careful consideration, we selected a disease that few people have ever heard of. An affliction of the very poor in 23 equatorial countries, the flesh-eating, bone-destroying disease mycetoma has spread misery for centuries. Yet its prevalence and etiology are largely unknown even today.

Read more...

The First Clinical Trial in Mycetoma

Drugs for Neglected Diseases initiative and Eisai Co., Ltd. to Test Drug Candidate for Eumycetoma Patients suffering from virtually no R&D for this neglected disease.

[Basel, Switzerland, Tokyo, Japan- 10 September 2015] The Drugs for Neglected Diseases initiative (DNDi) and the Japanese pharmaceutical company Eisai Co., Ltd. have signed an agreement to proceed with the clinical development of Eisai’santi-fungal drug fosravuconazole for the potential new treatment of eumycetoma, a fungal form of mycetoma, one of the world’s most neglected diseases.
Most probably transmitted through pricks to the skin by walking barefoot, eumycetoma is a chronic condition that affects people in tropical and subtropical regions, in particular across Africa, with the highest burden found in Sudan. The fungus penetrates the skin and causes massive tumour-like

Read more